Related Experiment Video
Updated: Mar 28, 2026
07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
2.5K
Treatment of Heart Failure With Reduced Ejection Fraction-Recent Developments
André Miguel Ramos Travessa1, Luiz Filipe de Menezes Falcão
11University of Lisbon and 2Santa Maria University Hospital, Lisbon North Hospital Center, Lisbon, Portugal.
American Journal of Therapeutics
|December 15, 2015
Summary
Heart failure with reduced ejection fraction (HFrEF) is a common condition impacting many. This review covers new diagnostic tools and treatments for HFrEF to improve patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Heart failure with reduced ejection fraction (HFrEF) accounts for over half of all heart failure cases.
- HFrEF leads to significant mortality, morbidity, and healthcare costs, particularly in developed nations.
- Improved diagnostic methods and therapeutic strategies are crucial for better HFrEF patient outcomes.
Purpose of the Study:
- To review the pathophysiology and diagnosis of HFrEF.
- To highlight emerging biomarkers and advanced echocardiographic techniques for left ventricular function assessment.
- To discuss recent advancements in pharmacological and non-pharmacological HFrEF treatments.
Main Methods:
- Literature review focusing on pathophysiology, diagnosis, and treatment of HFrEF.
- Emphasis on novel biomarkers and echocardiographic assessments.
- Analysis of recent pharmacological (e.g., LCZ696) and non-pharmacological therapies (CRT, ICDs).
Main Results:
- The review synthesizes current knowledge on HFrEF.
- Emerging biomarkers and echocardiographic methods offer improved diagnostic capabilities.
- Recent therapeutic developments show promise in managing HFrEF.
Conclusions:
- Accurate diagnosis and effective treatment of HFrEF are critical due to its high burden.
- Novel biomarkers and echocardiographic assessments are enhancing diagnostic precision.
- Recent therapeutic advancements, including LCZ696, cardiac resynchronization therapy, and implantable cardioverter defibrillators, represent significant progress in HFrEF management.
Related Concept Videos
01:30Heart Failure V: Medical Management
520
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
520
01:22Heart Failure VI: Adjunct Therapies
547
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
547
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
580
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
580
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:30Heart Failure VII: Nursing Interventions
692
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
692